U.S. DES Use Will Stabilize At Already Lowered Rates, Physicians Suggest
This article was originally published in The Gray Sheet
Executive Summary
Recommendations by an FDA advisory panel earlier this month will likely reinforce, but not amplify, already moderated usage patterns of drug-eluting stents in the U.S., doctors suggest